1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Wanbury
Wanbury Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Wanbury Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
26.67% Fall from 52W High
9.2
Dividend yield 1yr %
0
Wanbury Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Wanbury Quarterly Revenue
| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
133.45 Cr | 161.19 Cr | 131.11 Cr | 139.41 Cr | 145.5 Cr |
Wanbury Yearly Revenue
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|
578.64 Cr | 500.56 Cr | 512.69 Cr | 394.92 Cr | 368.59 Cr | 400.7 Cr |
Wanbury Quarterly Net Profit/Loss
| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
1.22 Cr | 8.02 Cr | 1.04 Cr | 33.63 Cr | 10.27 Cr |
Wanbury Yearly Net Profit/Loss
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|
55.96 Cr | -10.4 Cr | 81.47 Cr | -12.61 Cr | 64.46 Cr | -24.85 Cr |
Wanbury Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
255.90
10Day EMA
257.70
12Day EMA
257.00
20Day EMA
252.50
26Day EMA
248.90
50Day EMA
241.00
100Day EMA
237.10
200Day EMA
223.90
5Day SMA
262.60
10Day SMA
262.60
20Day SMA
254.30
30Day SMA
246.20
50Day SMA
227.30
100Day SMA
244.10
150Day SMA
244.50
200Day SMA
236.10
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 53744 Rs | 102418 Rs |
Week Rs | 96202 Rs | 217959 Rs |
Month Rs | 81471 Rs | 163767 Rs |
Resistance & Support
247.66
Pivot
Resistance
First Resistance
255.01
Second Resistance
265.61
Third Resistance
272.96
Support
First Support
237.06
Second support
229.71
Third Support
219.11
Relative Strength Index
48.40
Money Flow Index
58.77
MACD
8.18
MACD Signal
10.34
Average True Range
18.92
Average Directional Index
18.31
Rate of Change (21)
-3.62
Rate of Change (125)
9.65
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wanbury Ltd. | 237.23 | - | - | - | - | - | - | - | - | - | - | - | - | |
947.36 | 157 | 369.2 | 196.20 | -2.40% | 10.42% | -33.18% | -25.89% | -31.23% | 1.53% | 28.23 | 40.76 | 2.29 | ||
Anuh Pharma Ltd. | 169.55 | - | - | - | - | - | - | - | - | - | - | - | - | |
Fermenta Biotech Ltd. | 263.00 | - | - | - | - | - | - | - | - | - | - | - | - | |
Shukra Pharmaceuticals Ltd. | 15.99 | - | - | - | - | - | - | - | - | - | - | - | - | |
Kwality Pharmaceuticals Ltd. | 745.00 | - | - | - | - | - | - | - | - | - | - | - | - | |
Shree Ganesh Remedies Ltd. | 733.25 | - | - | - | - | - | - | - | - | - | - | - | - |
Wanbury Company background
Founded in: 1988
Wanbury Ltd (Formerly known Pearl Organics Limited) was incorporated in August, 1988. The Company is engaged in the business of pharmaceutical and related activities, including research.The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.In 200708, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007. Pursuant to the aforesaid Order of the Honble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/ each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008. Similarly, the Pharmaceutical Products of India Limited (PPIL) was merged with the Company effective from April 1, 2006. In terms of the said Scheme of Merger, the Company had issued 5,62,618 Equity Shares of face value of Rs. 10/ each to the Equity Shareholders of PPIL on 27 June, 2007, which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively.The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in Zurich,Switzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008.The novel product Cdense Gems was launched in May, 2008. The Company completed the restructuring of the Formulation Division during the year 2013. It launched, MyotolF, targeted at female infertility in 2013, it launched Folinine. The Companys newly launched products MyotolF (to treat polycystic ovarian syndrome) and CalK2 (in prevention and management of Osteoporosis) were labelled as one of the best launches in 2014.
Wanbury FAQs
How has Wanbury shares performed in the past ?
Wanbury share price in the past 1-year return was 56.45. The Wanbury share hit a 1-year low of Rs. 132.55 and a 1-year high of Rs. 325.
What is the market cap of Wanbury ?
The market cap of Wanbury is Rs. 802.39 Cr. as of 30/4/2025.
What is the current P/E ratio of Wanbury ?
The PE ratios of Wanbury is 43.72 as of 30/4/2025.
What is the current PB ratio of Wanbury ?
The PB ratios of Wanbury is 20.7 as of 30/4/2025
How to buy Wanbury shares?
You can easily buy Wanbury shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Wanbury stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account
